Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Treasury Shares (2020 - 2025)

Historic Treasury Shares for AC Immune (ACIU) over the last 6 years, with Q3 2025 value amounting to -$272516.2.

  • AC Immune's Treasury Shares fell 830.59% to -$272516.2 in Q3 2025 from the same period last year, while for Sep 2025 it was -$272516.2, marking a year-over-year decrease of 830.59%. This contributed to the annual value of -$248851.8 for FY2024, which is 9978.98% up from last year.
  • AC Immune's Treasury Shares amounted to -$272516.2 in Q3 2025, which was down 830.59% from -$263320.1 recorded in Q2 2025.
  • AC Immune's 5-year Treasury Shares high stood at $43.2 billion for Q4 2019, and its period low was $864.3 million during Q4 2021.
  • Moreover, its 5-year median value for Treasury Shares was -$242470.6 (2025), whereas its average is -$30.4 million.
  • In the last 5 years, AC Immune's Treasury Shares tumbled by 12421544.9% in 2021 and then surged by 10009.57% in 2022.
  • AC Immune's Treasury Shares (Quarter) stood at -$134.5 million in 2021, then surged by 100.1% to $128714.7 in 2022, then crashed by 92064.81% to -$118.4 million in 2023, then skyrocketed by 99.79% to -$248851.8 in 2024, then fell by 9.51% to -$272516.2 in 2025.
  • Its Treasury Shares stands at $864.3 million for Q4 2021, versus $21.6 billion for Q4 2020 and $43.2 billion for Q4 2019.